Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery
Phase 1 Unknown
30 enrolled
Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 3 Unknown
312 enrolled
Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Phase 3 Unknown
900 enrolled
LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer
Phase 1 Unknown
50 enrolled
Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
SU006668 in Treating Patients With Advanced Solid Tumors
Phase 1 Unknown
Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver
Phase 2 Unknown
20 enrolled
NB1011 in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 1/2 Unknown
Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
Unknown
800 enrolled
Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants
Phase 3 Unknown
900 enrolled
Increasing Colorectal Cancer Screening in African Americans
Phase 3 Unknown
896 enrolled
Personal Electronic Health Records in Improving Screening Rates for Colorectal Cancer
Phase NA Unknown
1,000 enrolled
Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer
Phase 2 Unknown
Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer
Phase 3 Unknown
1,050 enrolled
Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
Phase 1/2 Unknown
Fluorouracil and Biological Therapy in Treating Patients With Metastatic Kidney or Colorectal Cancer
Phase 1 Unknown
Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer
Phase 3 Unknown
336 enrolled
Aspirin and/or Folic Acid in Preventing Recurrent Colorectal Polyps
Phase NA Unknown
Lymphatic Mapping, Sentinel Lymph Node Analysis, and Blood Tests in Detecting and Predicting Early Micrometastases in Patients With Colorectal Cancer
Phase 2 Unknown
225 enrolled
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer
Phase 1 Unknown
9 enrolled
Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
46 enrolled
Study of Genes and the Environment in Patients With Colorectal Cancer in the East Anglia Region of the United Kingdom
Unknown
2,000 enrolled
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer
Phase NA Unknown
500 enrolled
External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases
Phase 2 Unknown
60 enrolled
S-1 and Bevacizumab in Treating Patients With Colorectal Cancer That is Recurrent or Cannot Be Removed by Surgery
Phase 2 Unknown
40 enrolled
Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 2 Unknown
51 enrolled
Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer
Unknown
96 enrolled
Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma
Phase 3 Unknown
Tocladesine in Treating Patients With Recurrent or Progressive Metastatic Colorectal Cancer
Phase 1 Unknown
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer
Phase 4 Unknown
58 enrolled
Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
Phase 2 Unknown
100 enrolled
Bevacizumab and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
47 enrolled
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
Phase 2 Unknown
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
Phase 3 Unknown
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2/3 Unknown
600 enrolled
Combination Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer With Liver Metastases or Lung Metastases That Are Potentially Removable by Surgery
Phase 2 Unknown
35 enrolled
Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin
Phase 2 Unknown
206 enrolled
Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal Adenocarcinoma
Phase 2 Unknown
Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Phase 3 Unknown
1,976 enrolled
Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer
Phase 3 Unknown
109 enrolled
Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Unknown
Fluorouracil, Leucovorin, and Irinotecan in Treating Patients With Recurrent or Refractory Metastatic Unresectable Colorectal Cancer
Phase 2 Unknown
DHA-Paclitaxel in Treating Patients With Metastatic Colorectal Cancer
Phase 2 Unknown
Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Unknown
78 enrolled